touchPODCAST

Bridging diagnostic and therapeutic gaps in Fabry disease management

touchEXPERT FOCUS for touchENDOCRINOLOGY, touchCARDIO and touchNEUROLOGY

Listen to a series of short expert interviews on timely diagnosis and individualized care for Fabry disease, using genetic and clinical insights. Our faculty discuss strategies to reduce diagnostic delays, identify clinically relevant genetic variants and tailor treatment based on each patient's genotype–phenotype correlations.

The experts

• Dr Raphael Schiffmann, Texas Christian University, Fort Worth, TX, USA
• Ms Dawn Laney, Emory Genetic Clinical Trials Center, Atlanta, GA, USA
• Dr Ozlem Goker-Alpan, Lysosomal Disorders Research and Treatment Center (LDRTC), Fairfax, VA, USA

This touchPODCAST is for HCPs outside of the UK.

This activity is funded by an independent medical education grant from Amicus Therapeutics Inc.

This activity is jointly provided by USF Health and touchIME.

For further information visit our websites: 
www.touchENDOCRINOLOGY.com www.touchCARDIO.com and www.touchNEUROLOGY.com

Applying patient and disease characteristics to guide R/M NPC treatment

touchCASES for touchONCOLOGY

Listen to three experts as they discuss how patient and disease characteristics may inform treatment selection in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC). They will discuss the cases of three patients which will cover first-line and second-line treatments as well as key considerations for their treatment plans in their patients' cases.

The experts:

• Dr Nabil Saba, Winship Cancer Institute, Emory University, Atlanta, GA, USA
• Dr Victoria Villaflor, Chao Family Comprehensive Cancer Center, UCI Health, Orange, CA, USA

This activity is for HCPs in the USA only

This activity is funded by an independent medical education grant from Coherus Biosciences.

This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/treatment-selection-in-r-m-npc/

 

Therapeutic advances in RRMM: What is the latest on practical application of BCMA-directed therapies?

touchEXPERT FOCUS for touchHAEMATOLOGY and touchONCOLOGY

Listen to a series of short expert interviews on the role of B-cell maturation antigen (BCMA)-directed therapies in relapsed/refractory multiple myeloma (RRMM). The faculty discuss patient selection, treatment tailoring and strategies to manage side effects, providing practical guidance for integrating BCMA-targeting approaches into care.

The experts

• Prof. Jesús San Miguel, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain
• Prof. Pieter Sonneveld, Erasmus University Medical Center, Rotterdam, The Netherlands
• Dr Francesca Gay, University of Torino, Italy

This touchPODCAST is for HCPs outside of the USA.

This activity is funded by an independent medical education grant from GSK.

This activity is provided by touchIME.
touchIME is an EBAC® accredited provider.

For further information visit our websites: www.touchHAEMATOLOGY.com and www.touchONCOLOGY.com 

Phacoemulsification in cataract surgery: Evolving options to optimize refractive outcomes

touchEXPERT FOCUS for touchOPHTHALMOLOGY

Listen to a series of short interviews with leading experts on phacoemulsification in cataract surgery. The faculty discuss optimizing fluidics and ultrasound energy, ophthalmic viscosurgical device selection, and integrating technological advances in phacoemulsification into clinical practice.

The experts:

• Dr Ike K Ahmed, Prism Eye Institute, Toronto, ON, Canada; John A. Moran Eye Center, University of Utah, Salt Lake City, UT, USA
• Dr David F Chang, University of California, San Francisco, CA, USA; Altos Eye Physicians, Los Altos, CA, USA
• Dr Jennifer Loh, Loh Ophthalmology Associates, Miami, FL, USA

This touchPODCAST is for HCPs in the USA, Latin America and Canada only.

This activity is funded by an independent medical education grant from Alcon Vision, LLC and Johnson & Johnson Surgical Vision, Inc.

The activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchophthalmologyime.org/phacoemulsification-cataract-surgery/

 

 

Stargardt disease: Improving awareness, diagnosis and patient support

touchEXPERT FOCUS for touchOPHTHALMOLOGY

Listen to a series of interviews with Prof. Elias Traboulsi on the clinical presentation, diagnosis and management of patients with Stargardt disease. Prof. Traboulsi shares key clinical characteristics and retinal imaging results indicative of Stargardt disease, discusses the right tools to use to accurately and promptly diagnose the condition, and reviews supportive care strategies to maximize patients’ functional vision and improve their wellbeing. 

The expert:

• Prof. Elias Traboulsi, Cleveland Clinic, Cleveland, OH, USA

This touchPODCAST is for HCPs in the USA only.

This activity is funded by an independent medical education grant from Alkeus Pharmaceuticals, Inc.

The activity is jointly provided by USF Health and touchIME.

For further information visit our website: www.touchOPHTHALMOLOGY.com

Mastering DKA management: From pathophysiology to prevention and ketone monitoring strategies

touchTALKS for touchENDOCRINOLOGY 

Listen to Prof. Jennifer Sherr, as she discusses key updates on the prevention and management of DKA. The discussion covers the clinical features and aetiology of DKA, its impact on people living with diabetes, the underlying metabolic pathways, risk factors, common triggers, and the pillars of management. Prof. Sherr also explores strategies for prevention and early intervention plus the advantages, drawbacks and recent developments in ketone monitoring.

The experts

• Prof. Jennifer Sherr, Yale School of Medicine, New Haven, CT, US

This touchPODCAST is for HCPs outside of the UK only.

This activity is funded by an independent medical education grant from Abbott Diabetes Care Inc.
This activity is jointly provided by USF Health and touchIME.

touchIME is an EBAC® accredited provider. 

For further information visit our website: 
www.touchENDOCRINOLOGY.com

A case-based discussion on PAH: Optimizing early detection, risk stratification and treatment decision-making

touchCASES for touchRESPIRATORY and touchCARDIO

This touchCASES activity presents expert-led discussions exploring three clinical cases of pulmonary arterial hypertension (PAH). Through these detailed cases, the expert faculty examine a range of clinical presentations and highlight critical decision points across the patient journey, from initial diagnosis and risk stratification to treatment initiation and escalation.

The experts:

• Dr Athénaïs Boucly, University of Paris-Saclay, Le Kremlin-Bicêtre, Paris, France
• Prof. Pilar Escribano Subìas, Complutense University of Madrid, Spain

This touchPODCAST is for HCPs outside the UK

This activity is provided by an independent medical education grant from Merck Sharp & Dohme LLC. The activity is jointly provided by USF Health and touchIME.

touchIME is an EBAC® accredited provider

For further information, visit our websites: www.touchRESPIRATORY.com and www.touchCARDIO.com

Continuous glucose monitoring for cardiovascular risk reduction: The next frontier in preventive care

touchEXPERT FOCUS for touchCARDIO and touchENDOCRINOLOGY

Listen to two experts discuss how continuous glucose monitoring (CGM) can help identify and manage cardiovascular risk in people with or without diabetes. They explore the role of glycaemic variability, the limitations of conventional glucose metrics, and the added value of CGM, including recent advances and patient education to support effective use.

The experts:

• Dr Eden Miller, Diabetes and Obesity Care, Bend, OR, USA
• Dr Ian J Neeland, Case Western Reserve University, and Harrington Heart and Vascular Institute, University Hospitals Cleveland, OH, USA

This activity is for HCPs outside of the UK.

This activity is funded by an independent medical education grant from Abbott Diabetes Care Inc.

This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.

For further information visit our website: www.touchCARDIO.com and www.touchENDOCRINOLOGY.com

HER2 as a targetable biomarker in gastrointestinal oncology

touchEXPERT FOCUS for touchONCOLOGY

Listen to a series of short interviews with three leading experts as they discuss the use of HER2 as a targetable biomarker in gastrointestinal oncology. The faculty cover the clinical significance of HER2 alterations, best practices for biomarker testing, key clinical trial data on efficacy and safety, and the role of HER2-targeted therapies in both common and rare GI cancers. They also address retesting at progression, management of adverse events, and emerging treatment approaches.

The experts

• Dr Yelena Janjigian, Memorial Sloan Kettering Cancer Center, New York, NY, USA
• Prof. Eric Van Cutsem, University of Leuven, Leuven, Belgium
• Prof. Florian Lordick, University of Leipzig, Leipzig, Germany

This touchPODCAST is for HCPs outside of the UK

This activity is funded by an independent medical education grant from AstraZeneca. 

This activity is jointly provided by USF Health and touchIME. 
touchIME is an EBAC® accredited provider. 

For further information visit our website: 
www.touchONCOLOGY.com 

Navigating the evolving role of immunotherapy in advanced endometrial carcinoma

touchPANEL DISCUSSION for touchONCOLOGY

Listen to three leading international experts in gynaecological oncology as they discuss how immunotherapy is transforming the treatment of advanced endometrial carcinoma. The faculty explore how the latest data are shaping first-line treatment decisions, how to personalize therapy using biomarkers and molecular classification, and how to manage immune-related adverse events through practical monitoring strategies.

The experts

• Prof. Isabelle Ray-Coquard, Centre Léon Bérard, Lyon, France
• Prof. Nicoletta Colombo, University of Milan-Bicocca, Milan, Italy
• Dr Brian Slomovitz, Mount Sinai Medical Center, Miami, FL, USA

This touchPODCAST is for HCPs outside of the UK only.

This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.

This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.

For further information visit our website: https://touchoncologyime.org/panel-icis-in-ec/